Cargando…

Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a highly malignant inherited arrhythmogenic disorder. Type 1 CPVT (CPVT1) is caused by cardiac ryanodine receptor (RyR2) gene mutations resulting in abnormal calcium release from sarcoplasmic reticulum. Dantrolene, an inhibitor of sarco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penttinen, Kirsi, Swan, Heikki, Vanninen, Sari, Paavola, Jere, Lahtinen, Annukka M., Kontula, Kimmo, Aalto-Setälä, Katriina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425399/ https://www.ncbi.nlm.nih.gov/pubmed/25955245 http://dx.doi.org/10.1371/journal.pone.0125366

Ejemplares similares

Correction: Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models
por: Penttinen, Kirsi, et al.
Publicado: (2015)

Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed Afterdepolarizations
por: Kujala, Kirsi, et al.
Publicado: (2012)

Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients
por: Pölönen, R. P., et al.
Publicado: (2018)

Analysis of Drug Effects on iPSC Cardiomyocytes with Machine Learning
por: Juhola, Martti, et al.
Publicado: (2020)

Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia
por: Marjamaa, Annukka, et al.
Publicado: (2009)

Automatic Optimization of an in Silico Model of Human iPSC Derived Cardiomyocytes Recapitulating Calcium Handling Abnormalities
por: Paci, Michelangelo, et al.
Publicado: (2018)

HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity
por: Penttinen, Kirsi, et al.
Publicado: (2023)

KCNE1 D85N polymorphism — a sex-specific modifier in type 1 long QT syndrome?
por: Lahtinen, Annukka M, et al.
Publicado: (2011)

Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation
por: Koponen, Mikael, et al.
Publicado: (2020)

Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Gaballah, Mahmoud, et al.
Publicado: (2022)

Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes
por: Kuusela, Jukka, et al.
Publicado: (2016)

Distinct electrophysiological and mechanical beating phenotypes of long QT syndrome type 1-specific cardiomyocytes carrying different mutations
por: Kiviaho, Anna L., et al.
Publicado: (2015)

A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production
por: Manzini, Stefano, et al.
Publicado: (2015)

Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays
por: Maria Cherian, Reeja, et al.
Publicado: (2022)

The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
por: Li, Yukun, et al.
Publicado: (2022)

Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells
por: Kiamehr, Mostafa, et al.
Publicado: (2017)

Detection of genetic cardiac diseases by Ca(2+) transient profiles using machine learning methods
por: Juhola, Martti, et al.
Publicado: (2018)

Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
por: Viiri, Leena E., et al.
Publicado: (2019)

Coronary artery disease patient-derived iPSC-hepatocytes have distinct miRNA profile that may alter lipid metabolism
por: Alexanova, Anna, et al.
Publicado: (2023)

hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single Cells
por: Shah, Disheet, et al.
Publicado: (2020)

Improvements in Maturity and Stability of 3D iPSC-Derived Hepatocyte-like Cell Cultures
por: Suominen, Siiri, et al.
Publicado: (2023)

Novel Analysis Software for Detecting and Classifying Ca(2+) Transient Abnormalities in Stem Cell-Derived Cardiomyocytes
por: Penttinen, Kirsi, et al.
Publicado: (2015)

Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients: Koponen et al. Follow-up of adult LQTS patients
por: Koponen, Mikael, et al.
Publicado: (2018)

Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia
por: Jung, Christian B, et al.
Publicado: (2012)

Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
por: Lahti, Anna L., et al.
Publicado: (2012)

Maturation of human pluripotent stem cell derived cardiomyocytes is improved in cardiovascular construct
por: Vuorenpää, Hanna, et al.
Publicado: (2017)

Calcium Transients Closely Reflect Prolonged Action Potentials in iPSC Models of Inherited Cardiac Arrhythmia
por: Spencer, C. Ian, et al.
Publicado: (2014)

Impact of High-Dose Irradiation on Human iPSC-Derived Cardiomyocytes Using Multi-Electrode Arrays: Implications for the Antiarrhythmic Effects of Cardiac Radioablation
por: Kim, Jae Sik, et al.
Publicado: (2021)

Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy
por: Ojala, Marisa, et al.
Publicado: (2016)

Catecholaminergic Polymorphic Ventricular Tachycardia
por: Abbas, Mohamed, et al.
Publicado: (2022)

Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy
por: Prajapati, Chandra, et al.
Publicado: (2018)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018)

iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)

Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)

iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020)

CytoSpectre: a tool for spectral analysis of oriented structures on cellular and subcellular levels
por: Kartasalo, Kimmo, et al.
Publicado: (2015)

Malignant hyperthermia and dantrolene sodium
por: Kim, Ha Jung, et al.
Publicado: (2019)

The Junctophilin-2 Mutation p.(Thr161Lys) Is Associated with Hypertrophic Cardiomyopathy Using Patient-Specific iPS Cardiomyocytes and Demonstrates Prolonged Action Potential and Increased Arrhythmogenicity
por: Valtonen, Joona, et al.
Publicado: (2023)

Electrical Field Stimulation with a Novel Platform: Effect on Cardiomyocyte Gene Expression but not on Orientation
por: Kujala, Kirsi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b32smdasu16d2dqjccl1sdnv42